rs515726143
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_015474.4(SAMHD1):c.1609-1G>T variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000657 in 152,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_015474.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Aicardi-Goutieres syndrome 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- Moyamoya diseaseInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- Aicardi-Goutieres syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial chilblain lupusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- chilblain lupus 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- chilblain lupusInheritance: AD Classification: NO_KNOWN Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SAMHD1 | NM_015474.4 | c.1609-1G>T | splice_acceptor_variant, intron_variant | Intron 14 of 15 | ENST00000646673.2 | NP_056289.2 | ||
| SAMHD1 | NM_001363729.2 | c.1504-1G>T | splice_acceptor_variant, intron_variant | Intron 13 of 14 | NP_001350658.1 | |||
| SAMHD1 | NM_001363733.2 | c.1609-1G>T | splice_acceptor_variant, intron_variant | Intron 14 of 15 | NP_001350662.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SAMHD1 | ENST00000646673.2 | c.1609-1G>T | splice_acceptor_variant, intron_variant | Intron 14 of 15 | NM_015474.4 | ENSP00000493536.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74316 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 5 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site is associated with altered splicing resulting in multiple RNA products (PMID: 19525956). ClinVar contains an entry for this variant (Variation ID: 1032693). Disruption of this splice site has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 19525956). This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change affects an acceptor splice site in intron 14 of the SAMHD1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SAMHD1 are known to be pathogenic (PMID: 19525956, 22461318). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at